Advertisement
Screener

Standard BioTools Inc. (LAB) ROA

STANDARD BIOTOOLS INC. ROA

Return on assets (ROA) is the profit a company earns for every dollar of assets it uses, shown as a percentage. It is net income divided by total assets, and the table shows both amounts. Because assets are funded by lenders as well as shareholders, ROA is not inflated by borrowing the way ROE can be, and it is naturally lower for businesses that need many factories, stores or other assets. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • STANDARD BIOTOOLS INC. roa for the quarter ending 2026-06-30 was 13.54%, a change of 35.17% year-over-year.
  • STANDARD BIOTOOLS INC. roa for the quarter ending 2026-03-31 was 12.24%, a change of 35.14% year-over-year.
  • STANDARD BIOTOOLS INC. roa for the quarter ending 2025-12-31 was -13.19%, a change of 9.49% year-over-year.
  • STANDARD BIOTOOLS INC. roa for the quarter ending 2025-09-30 was -23.77%, a change of -5.49% year-over-year.
  • STANDARD BIOTOOLS INC. roa for fiscal 2025 was -13.19%, a change of 9.49% from fiscal 2024.
  • STANDARD BIOTOOLS INC. roa for fiscal 2024 was -22.68%, a change of 0.43% from fiscal 2023.
  • STANDARD BIOTOOLS INC. roa for fiscal 2023 was -23.11%, a change of 25.60% from fiscal 2022.
  • STANDARD BIOTOOLS INC. roa for fiscal 2022 was -48.70%, a change of -27.18% from fiscal 2021.
Available history
2010-12-31 to 2026-06-30
Data captured

Historical ROA

DateROANet income 12 monthNet income 3 monthTotal assets
2026-06-3013.54%$84.91M-$26.76M$627.22M
2026-03-3112.24%$78.21M$127.07M$639.11M
2025-12-31-13.19%-$74.9M$19.28M$567.75M
2025-09-30-23.77%-$128.25M-$34.69M$539.64M
2025-06-30-21.64%-$120.5M-$33.46M$556.97M
2025-03-31-22.91%-$132.76M-$26.03M$579.6M
2024-12-31-22.68%-$138.89M-$34.07M$612.35M
2024-09-30-18.28%-$124.59M-$26.94M$681.54M
2024-06-30-16.74%-$118.65M-$45.72M$708.73M
2024-03-31-11.57%-$89.97M-$32.16M$777.67M
2023-12-31-23.11%-$74.66M-$19.78M$323.07M
2023-09-30-22.32%-$75.73M-$21.00M$339.29M
2023-06-30-23.65%-$84.15M-$17.04M$355.83M
2023-03-31-35.15%-$130.65M-$16.84M$371.65M
2022-12-31-48.70%-$190.1M-$20.84M$390.31M
2022-09-30-43.06%-$178.68M-$29.43M$414.92M
2022-06-30-36.97%-$163.1M-$63.54M$441.12M
2022-03-31-42.92%-$116.7M-$76.29M$271.94M
2021-12-31-21.52%-$59.24M-$9.43M$275.21M
2021-09-30-24.04%-$67.83M-$13.84M$282.19M
2021-06-30-20.73%-$59.99M-$17.14M$289.32M
2021-03-31-18.30%-$55.86M-$18.82M$305.2M
2020-12-31-16.33%-$53.02M-$18.03M$324.76M
2020-09-30-14.76%-$47.68M-$6.00M$322.98M
2020-06-30-19.33%-$54.57M-$13.02M$282.35M
2020-03-31-19.06%-$55.31M-$15.98M$290.22M
2019-12-31-24.47%-$64.79M-$12.69M$264.81M
2019-09-30-24.83%-$66.88M-$12.89M$269.39M
2019-06-30-24.22%-$68.74M-$13.75M$283.79M
2019-03-31-24.44%-$71.23M-$25.46M$291.45M
2018-12-31-19.43%-$59.01M-$14.78M$303.65M
2018-09-30-21.68%-$54.7M-$14.75M$252.29M
2018-06-30-21.57%-$55.89M-$16.24M$259.1M
2018-03-31-20.98%-$56.58M-$13.25M$269.7M
2017-12-31-21.07%-$60.54M-$10.46M$287.35M
2017-09-30-23.21%-$67.78M-$15.94M$292M
2017-06-30-25.70%-$71.62M-$16.93M$278.71M
2017-03-31-25.06%-$73.3M-$17.20M$292.47M
2016-12-31-24.80%-$75.99M-$17.70M$306.4M
2016-09-30-22.21%-$71.17M-$19.79M$320.42M
2016-06-30-17.73%-$60.65M-$18.62M$342.03M
2016-03-31-16.16%-$57.27M-$19.88M$354.44M
2015-12-31-14.41%-$53.32M-$12.88M$370.05M
2015-09-30-13.58%-$51.38M-$9.27M$378.49M
2015-06-30-14.37%-$55.9M-$15.24M$389.13M
2015-03-31-13.50%-$53.35M-$15.93M$395.03M
2014-12-31-12.96%-$52.83M-$10.94M$407.56M
2014-09-30-11.34%-$46.53M-$13.79M$410.39M
2014-06-30-8.86%-$37.03M-$12.68M$417.75M
2014-03-31-6.68%-$28.39M-$15.41M$424.72M
2013-12-31-14.14%-$16.53M-$4.64M$116.92M
2013-09-30-13.55%-$15.49M-$4.29M$114.24M
2013-06-30-13.71%-$15.35M-$4.05M$111.97M
2013-03-31-14.03%-$15.89M-$3.55M$113.24M
2012-12-31-16.73%-$19.02M-$3.60M$113.73M
2012-09-30-16.12%-$18.88M-$4.15M$117.1M
2012-06-30-29.59%-$19.22M-$4.58M$64.93M
2012-03-31-30.88%-$21.82M-$6.69M$70.67M
2011-12-31-28.33%-$22.47M-$3.46M$79.33M
2011-09-30-26.74%-$22.09M-$4.49M$82.6M
2011-06-30-24.50%-$20.98M-$7.19M$85.66M

Annual ROA

DateROANet income 12 monthTotal assets
2025-12-31-13.19%-$74.9M$567.75M
2024-12-31-22.68%-$138.89M$612.35M
2023-12-31-23.11%-$74.66M$323.07M
2022-12-31-48.70%-$190.1M$390.31M
2021-12-31-21.52%-$59.24M$275.21M
2020-12-31-16.33%-$53.02M$324.76M
2019-12-31-24.47%-$64.79M$264.81M
2018-12-31-19.43%-$59.01M$303.65M
2017-12-31-21.07%-$60.54M$287.35M
2016-12-31-24.80%-$75.99M$306.4M
2015-12-31-14.41%-$53.32M$370.05M
2014-12-31-12.96%-$52.83M$407.56M
2013-12-31-14.14%-$16.53M$116.92M
2012-12-31-16.73%-$19.02M$113.73M
2011-12-31-28.33%-$22.47M$79.33M
2010-12-31-68.15%-$16.9M$24.8M

Similar stocks

Stock NameCountryMarket CapPE Ratio
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Upstream Bio, Inc. (UPB)United States$0.284B-2.42
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Sagimet Biosciences Inc. (SGMT)United States$0.279B
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01